Woman and Man
- | Country :
- Germany
- United Kingdom
- Norway
- The 3 others...
- | organs : -
- | Specialty : -
Extract
Patients with refractory or relapsed hematologic malignancies will receive CP-4055 intravenously(IV) on Day 1-5 every three weeks until complete response or disease worsening/progressing
Inclusion criteria
- hematologic malignancies ,AML